Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop

Coffey MJ, DeCory HH, Lane SS

Clinical Ophthalmology 2013, 7:299-312

Published Date: 13 February 2013